MyFinsight
Home
About
Contact
abvc: the income statement
Download
Download image
Comprehensive loss
-$1,243,277
(-671.40%↓ Y/Y)
Foreign currency
translation adjustment
$3,236
(-87.25%↓ Y/Y)
Net loss attributed
to abvc and...
-$1,246,513
(-568.15%↓ Y/Y)
Net loss
attributable to...
-$41,010
(-178.43%↓ Y/Y)
Net loss
-$1,287,523
(-858.89%↓ Y/Y)
Provision for income tax
expense
$527
(48.45%↑ Y/Y)
Loss before
provision income tax
-$1,286,996
(-861.04%↓ Y/Y)
Revenues
$795,950
(104.47%↑ Y/Y)
Total other income
(expenses)
-$118,586
(35.50%↑ Y/Y)
Loss from operations
-$1,168,410
(-2439.30%↓ Y/Y)
Other income
(expenses)
$2,194
(-86.99%↓ Y/Y)
Operating sublease income
$29,680
(147.33%↑ Y/Y)
Interest income
$47,287
(6.84%↑ Y/Y)
Gross (loss) profit
$795,950
(104.62%↑ Y/Y)
Loss on investment in
equity securities
-$54,235
(20.11%↑ Y/Y)
Gain (loss) on
foreign exchange
-$112,553
(-469.89%↓ Y/Y)
Total operating
expenses
$1,964,360
(479.40%↑ Y/Y)
Interest expense
$30,959
(-85.90%↓ Y/Y)
Stock-based compensation
$1,136,217
Research and development
expenses
$29,890
(-20.98%↓ Y/Y)
Selling, general and
administrative expenses
$798,253
(165.02%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)